Quick Answer
iBio, Inc. reported Net Income of -$18.38 million for fiscal year 2025.
iBio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$18.38M | +26.2% |
| 2024 | -$24.91M | +61.7% |
| 2023 | -$65.01M | -29.2% |
| 2022 | -$50.30M | -116.8% |
| 2021 | -$23.21M | -41.2% |
| 2020 | -$16.44M | +6.6% |
| 2019 | -$17.59M | -9.2% |
| 2018 | -$16.11M | -10.8% |
| 2017 | -$14.53M | -48.8% |
| 2016 | -$9.76M | -47.4% |
| 2015 | -$6.62M | -80.7% |
| 2014 | -$3.67M | +40.9% |
| 2013 | -$6.20M | -9.2% |
| 2012 | -$5.68M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$8.99M | -106.1% | -57.2% |
| September 30, 2025 | -$5.72M | -43.4% | -17.7% |
| March 31, 2025 | -$4.86M | -53.2% | -11.4% |
| December 31, 2024 | -$4.36M | +46.9% | -9.4% |
| September 30, 2024 | -$3.99M | +30.6% | -25.8% |
| March 31, 2024 | -$3.17M | +56.5% | +61.4% |
| December 31, 2023 | -$8.21M | +75.5% | -42.9% |
| September 30, 2023 | -$5.75M | +68.3% | +21.2% |
- iBio, Inc. showed an increase of +26.2% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, iBio, Inc.’s net income has declined by 223.8% (from -$5.68 million to -$18.38 million).
- The most recent figure is from iBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: